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Abstract
Background
The burden of human leptospirosis in Uganda is unknown. We estimated the seropreva-
lence of Leptospira antibodies, probable acute/recent leptospirosis, and risk factors for
seropositivity in humans in rural Western Uganda.
Methodology and Principal Findings
359 non-pregnant adults visiting the Kikuube and Kigorobya Health Centers were sequen-
tially recruited during March and April 2014. A health history survey and serum were col-
lected from consented participants. Overall, 69% reported having fever in the past year,
with 49% reporting malaria, 14%malaria relapse, 6% typhoid fever, 3% brucellosis, and 0%
leptospirosis. We tested sera by microscopic agglutination test (MAT) against eight Leptos-
pira serovars representing seven serogroups. Leptospira seroprevalence was 35% (126/
359; 95%CI 30.2–40.3%) defined as MAT titer 1:100 for any serovar. The highest preva-
lence was against L. borgpetersenii Nigeria (serogroup Pyrogenes) at 19.8% (71/359; 95%
CI 15.9–24.4%). The prevalence of probable recent leptospirosis (MAT titer1:800) was
1.9% (95%CI 0.9–4.2%) and uniquely related to serovar Nigeria (serogroup Pyrogenes).
Probable recent leptospirosis was associated with having self-reported malaria within the
past year (p = 0.048). Higher risk activities included skinning cattle (n = 6) with 12.3 higher
odds (95%CI 1.4–108.6; p = 0.024) of Leptospira seropositivity compared with those who
had not. Participants living in close proximity to monkeys (n = 229) had 1.92 higher odds
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(95%CI 1.2–3.1; p = 0.009) of seropositivity compared with participants without monkeys
nearby.
Conclusions/Significance
The 35% prevalence of Leptospira antibodies suggests that exposure to leptospirosis is
common in rural Uganda, in particular the Nigeria serovar (Pyrogenes serogroup). Leptospi-
rosis should be a diagnostic consideration in febrile illness and “smear-negative malaria” in
rural East Africa.
Author Summary
Leptospirosis is an emerging zoonotic disease caused by bacteria of the genus Leptospira.
Despite its relatively common frequency, mild/moderate leptospirosis often goes unrecog-
nized, due to its usually non-specific symptoms of fever, vomiting, and malaise. Knowl-
edge of leptospirosis in Uganda is limited, and the disease may often be misdiagnosed as
malaria. This study sought to define the percentage of healthcare seeking Ugandans in
rural Western Uganda who have antibodies to Leptospira in their blood, suggesting prior
exposure. We found 35% of study participants had antibodies to at least one Leptospira
serovar, predominantly L. borgpetersenii sv Nigeria representing the Pyrogenes serogroup
(20% of all participants). Individuals with increased odds of having antibodies to lepto-
spires included participants who skinned cattle and those who reported monkeys near
their home. Individuals who self-reported recent diagnosis of malaria were more likely to
have leptospirosis antibodies. Antibodies to leptospirosis are not lifelong, typically lasting
a few years. The high 35% seroprevalence suggests there is ongoing exposure. Further
studies are needed to understand the burden of leptospirosis in rural Africa, the risk fac-
tors associated with exposure, and the public health opportunities to mitigate
leptospirosis.
Introduction
Leptospirosis is a zoonotic bacterial disease with a worldwide distribution that is endemic in
subtropical and tropical countries. Transmission occurs through exposure to urine or aborted
tissues of infected animals, either through direct contact with carrier animals or contact with
contaminated water or soil [1]. Leptospira is a Genus of spirochetes that comprise 20 species
and almost 300 different serovars (sv). They have a large range of mammalian hosts which
carry specifically adapted serovars in their renal tubules and excrete them in the environment
for months or years. Humans are considered accidental hosts who most likely do not transmit
the bacteria [1–3]. Infection patterns vary depending on the climate and rainfall, and the socio-
economic, occupational, or recreational activities which bring a susceptible host into contact
with infected water or animals. In tropical regions, leptospirosis outbreaks in animals and
humans often occur after flooding [4].
Human incidence of leptospirosis is commonly underreported due to low awareness of the
disease, lack of surveillance systems in place, nonspecific clinical symptoms, and the complex-
ity of diagnosis [4,5]. The World Health Organization (WHO) Leptospirosis Epidemiology
Reference Group (LERG) estimated in a 2015 systematic literature review that the annual inci-
dence was 1.03 million cases (95%CI, 305,000–1,750,000) and 58,900 deaths (95%CI, 23,800–
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95,800) due to leptospirosis worldwide [6]. East Africa had an estimated annual incidence of
25.6 (95%CI 9.3–43.3) per 100,000 population [6].
Studies on leptospirosis in Uganda have only been published in animals. In 2011, Millan
et al. [7] sampled 105 dogs around three national parks using the Microscopic Agglutination
test (MAT) and found 27% (95%CI, 19–36) seropositivity; across six serovars, most frequently
Icterohaemorragiae and Canicola [7]. In 2014, Atherstone found a 29% seropositivity in cattle
(n = 92) and 42% seropositivity in buffaloes (n = 92) for LeptospiraHardjo serovar when using
an ELISA [8].
Elsewhere in East Africa, a few studies on Leptospira prevalence in humans and animals
have been published. A recently published systematic literature review on leptospirosis in
Africa reported a prevalence of acute human leptospirosis ranging from 2.3% to 19.8% in 11
studies in hospital patients with acute febrile illness and compatible symptoms [9]. A study
conducted in Tanzania in 2013 estimated 75–102 clinical leptospirosis cases per 100,000 popu-
lation [10]. In two studies of Tanzanian cattle in 2011 and 2014, a 30% seroprevalence was
found (n = 1758) using the MAT [11,12]. Assenga et al. reported a seroprevalence of 29% in
buffaloes (n = 38), 20% in rodents (n = 207), and 30% in humans (n = 267) [12]. The most
prevalent serovar was Hardjo in humans (16%) and cattle (18%), but in rodents was Australis
(19%). These results point to a human-cattle transmission pathway, which is plausible in the
agro-pastoral environment of Tanzania [12].
Although cross-sectional seroprevalence studies mainly indicate past exposure to lepto-
spires, persons with high titers may have recent acute disease or recent recurrent exposure.
Sero-conversion may serve as an imperfect, proxy measure of incidence. Biggs et al. demon-
strated 33% of 870 acute febrile illness patients had antibodies against Leptospira serovar in
Moshi, Tanzania in 2007–2008 [13]. Further, 8.8% of 870 had seroconverted with a greater
than four-fold increase in serumMAT titer on convalescent testing, consistent with “confirmed
leptospirosis”. An additional 3.6% had titers of1:800 in one tested sample, and therefore
suited the case definition of “probable recent leptospirosis” [13]. Among their laboratory con-
firmed cases of leptospirosis, 44% had previously received the clinical diagnosis of malaria.
Given these foundational studies and the similar eco-systems and agro-pastoral activities
between Uganda and Tanzania, leptospirosis may present an unrecognized disease burden in
Uganda, particularly when misdiagnosed as malaria or another febrile illness. This study’s
objectives were to estimate the seroprevalence of Leptospira antibodies and probable recent lep-
tospirosis in humans in rural western Uganda. Secondary objectives included analysis of risk
factors for seropositivity against specific serovars and for probable recent leptospirosis.
Description of the Study Environment
Hoima District in western Uganda presents unique challenges regarding diagnosis and man-
agement of leptospirosis. The district lies on the eastern coast of Lake Albert, the northwestern
most of the African Great Lakes. Hoima contains a widely varied ecology, with protected con-
servation areas, mixed-use pastoral farm lands, coastal fishing villages, and urbanized towns.
The climate is tropical, with average rainfall of 1270 mm/year, average temperatures above
21°C and two rainy seasons fromMarch-May and August-November which can bring inter-
mittent flooding [14]. Malaria is holoendemic and most commonly diagnosed by microscopy,
with greater than 80% of children under the age of ten infected [15]. As a result of these high
levels of parasitemia, febrile illnesses may be routinely diagnosed as malaria, obscuring the true
burden of other infectious pathogens like leptospirosis. Over a quarter of the district’s 550,000
inhabitants live in poverty [14]. Occupations focus predominantly around subsistence agricul-
ture characterized by mixed farming and pastoralism (i.e. livestock). Novel trends show
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increasing land area devoted to rice farming that requires periodic flooding and recent oil and
gas extraction [16,17]. The district also contains the UNHCR refugee settlement at Kyangwali
sub-county, where>20,000 refugees from Democratic Republic of Congo are located [16].
These mixed communities, land use patterns, and ecologies create a complex milieu allowing
zoonotic disease transmission. Hoima’s community Health Centres serve this heterogeneous
patient population.
Methods
Study Design, Data Collection and Management
Study participants were recruited at the Kikuube and Kigorobya Health Center IV’s within
Hoima District during March and April 2014. The Health Centre IV’s provide service to
~100,000 Ugandans each. Every non-pregnant adult aged 18 years who presented to the
health center, either as a patient or as a caregiver, was invited to participate. Common reasons
for seeking health care at these centers included: obstetric complications, occupational trauma,
and acute febrile illnesses. Demographic interviews were conducted by clinical officers, and
serum samples were collected from both field sites on a daily basis. Samples were centrifuged
and then stored in -20°C freezers at the Hoima Regional Referral Hospital. Sera were trans-
ported on ice to the Ministry of Agriculture, Animal Industry, and Fisheries in Entebbe, and
stored at -80°C prior to testing.
Participant Survey
Survey data were collected in four major areas (S1 Text). First, information on demographics
including age, gender, education, religion, profession, sub-county of residence, and duration of
residence in Hoima was collected. Second, past medical history assessed for prior diagnosis
with febrile diseases such as malaria, typhoid, brucellosis, leptospirosis, and hemorrhagic
fevers. Additional questions assessed recent history of fever within the past year, whether the
participant had seen a physician and the outcome of any treatment for febrile illness. Third,
animal contact was evaluated using quantity of animals owned, animal product consumption
during the last month, involvement in cattle or beef processing within the past two weeks, and
the presence or absence of wildlife, such as rats or monkeys, near the home. Finally, questions
regarding the participant’s domestic environment included the fabrication material used to
construct their home and their major sources of drinking water (Table 1). Data on acute clini-
cal status, such as fever of the patient at the Health Centre, was not collected.
Serological Testing
The MAT is the reference test for distinguishing among leptospirosis serovars and giving valu-
able information on past exposures [2]. Due to the absence of MAT laboratory capacity in
Uganda and the lack of isolated and cultured local strains, Leptospira serovars and correspond-
ing antisera were imported from the OIE Reference Laboratory Royal Tropical Institute (KIT),
Holland. A panel of eleven serovars from ten different serogroups (sg) was chosen based on the
recommendations of experts from KIT, represented in Table 2. These serovars were selected to
represent a wide variety of serogroups with minimal crossreactivity, most of which had been
isolated from other parts of Africa. Leptospira Kirschneri sv Soikoine, Leptospira borgpetersenii
sv Kenya and Leptospira borgpetersenii sv Nona were not tested, as these antigens did not grow
well during the testing phase or were contaminated and not regarded fit for MAT testing.
MATs were performed in the framework of a capacity building course run by the authors Pear-
son and Dreyfus in conjunction with authors Alinaitwe and Kakooza. In an effort to partner
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Table 1. Frequencies of exposure variables, Leptospira seropositivity (any serovar) by exposure variable categories and the bivariable associa-
tion (odds ratio, OR) between an exposure variable and seropositivity against any serovar (Any) and sv Nigeria (Ni) in 359 participants from Hoima
District, Uganda.
Exposure Variable Categories N (%) Seropositivity N (%) OR (Any) 95% CI (Any) OR (Ni) 95% CI (Ni)
Health Center Kikuube 181 (50) 64 (35) ref ref
Kigorobya 178 (50) 54 (30) 0.8 0.5–1.2 0.9 0.5–1.5
Sex Women 263 (73) 85 (32) ref ref
Men 96 (27) 33 (34) 1.1 0.7–1.8 1.1 0.6–1.9
Age 18–29 155 (44) 54 (35) ref ref ref
30–39 91 (26) 26 (28) 0.7 0.4–1.3 0.4 0.2–2.1
40–49 59 (17) 19 (32) 0.9 0.5–1.7 1.1 0.5–2.2
>50 47 (13) 16 (34) 1.0 0.5–1.9 0.7 0.3–1.8
Education None 63 (18) 19 (16) ref ref
Primary 219 (61) 74 (63) 1.2 0.6–2.2 1.2 0.6–2.4
Secondary 68 (19) 21 (18) 1 0.5–2.2 0.7 0.3–1.7
Post-Secondary 9 (3) 4 (3) 1.9 0.4–7.7 1.2 0.2–6.6
Religion Christian 335 (93) 107 (32) ref ref
Muslim 14 (4) 6 (43) 1.6 0.5–4.6 - -
Traditional 10 (3) 3 (30) 0.9 0.2–3.5 1.0 0.2–4.6
Occupation Farming1 292 (81) 94 (32) 0.9 0.5–1.5 1.7 0.8–3.7
Domestic Work1 138 (38) 43 (31) 0.9 0.6–1.47 1.1 0.6–1.8
Time in Hoima (yrs) <1 16 (4) 7 (6) ref ref
1—<3 12 (3) 6 (5) 1.3 0.3–5.8 0.6 0.1–4.0
3—<5 7 (2) 2 (2) 0.5 0.1–3.5 1 -
5—<10 4 (1) 0 (0) 1 - 1 -
10+ 320 (89) 103 (87) 0.6 0.2–1.7 0.8 0.2–2.5
Livestock Contact Herding1 70 (20) 27 (38) 1.4 0.8–2.3 1.3 0.7–2.4
Milking1 25 (7) 5 (20) 0.5 0.2–1.3 0.8 0.2–2.3
Birthing1 9 (2.5) 0 (0) - - - -
Slaughtering1 6 (1.7) 3 (50) 2.1 0.4–10.4 2.1 0.4–11.4
Skinning1 6 (1.7) 5 (83) 10.6 1.2–91.9 4.2 0.8–21.2
Butchering1 3 (1) 3 (100) - - 2.0 0.2–22.8
High Risk Activity 12 No 351 (98) 3 (38) ref ref
Yes 8 (2) 5 (63) 3.5 0.8–15.0 2.5 0.6–10.7
High Risk Activity 23 No 285 (80) 45 (61) ref ref
Yes 74 (21) 29 (39) 1.4 0.8–2.4 1.3 0.7–2.4
Other Animal Contact Monkeys1 229 (64) 86 (37) 1.8 1.1–3.0 2.1 1.2–3.7
Baboons1 58 (16) 20 (34) 1.1 0.6–2.0 0.7 0.3–1.5
Chimpanzees1 43 (12) 15 (35) 1.1 0.6–2.1 0.9 0.4–2.1
Rats1 346 (96) 115 (33) 1.7 0.4–6.1 1.4 0.3–6.3
Bats1 180 (50) 57 (32) 0.9 0.6–1.48 1.0 0.6–1.6
Deer1 8 (2) 4 (50) 2.1 0.5–8.5 2.5 0.6–10.7
Type of Housing Mud, Thatch 171 (48) 53 (45) ref ref
Mud, Cow Dung, Thatch 2 (0.5) 0 (0) 1 - 1 -
Mud, Iron 101 (28) 35 (30) 1.2 0.7–2.0 1.3 0.7–2.3
Concrete, Iron 85 (24) 30 (25) 1.2 0.7–2.1 1 0.5–2.0
Past Medical History 1 year Fever1 249 (69) 78 (31) 0.8 0.5–1.3 0.9 0.5–1.6
Malaria1 175 (49) 52 (30) 0.8 0.5–1.2 0.7 0.4–1.2
Typhoid1 20 (6) 7 (35) 1.1 0.4–2.8 1.8 0.7–4.9
Brucellosis1 12 (3) 0 (0) - - - -
(Continued)
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equally with our Ugandan colleagues, development of MAT capacity in country was considered
an essential component of the project.
The serum aliquots were transferred to microtiter plates and stored at -80°C. The MAT
measured serum antibodies at doubling two-fold dilutions starting at 1:25 dilution up through
1:3200, as described previously [2]. Given the absence of information on prevalent serovars in
Uganda, serovars were considered representative of their serogroup, and within serogroup
cross-reactivity was not excluded.
Table 1. (Continued)
Exposure Variable Categories N (%) Seropositivity N (%) OR (Any) 95% CI (Any) OR (Ni) 95% CI (Ni)
Water Sources Piped water in home1 36 (10) 13 (36) 1.2 0.6–2.4 1.2 0.5–2.7
Bore Hole1 154 (43) 52 (34) 1.1 0.7–1.7 1.0 0.6–1.6
Well1 134 (37) 42 (31) 0.9 0.6–1.4 0.9 0.5–1.5
Public Tap1 20 (6) 5 (25) 0.7 0.2–1.9 0.7 0.2–2.5
Surface Water1 45 (13) 13 (29) 0.8 0.4–1.6 1.0 0.5–2.2
Sub-counties Kigorobya 171 (48) 52 (30) ref ref
Bugambe4 6 (2) 2 (33) 1.1 0.4–2.6 1.4 0.5–3.7
Kabwoya4 7 (2) 3 (43) 1.1 0.4–2.6 1.4 0.5–3.7
Kitoba4 2 (0.6) 1 (50) 1.1 0.4–2.6 1.4 0.5–3.7
Kyabigambire4 1 (0.3) 0 (0) 1.1 0.4–2.6 1.4 0.5–3.7
Kyangwali4 1 (0.3) 0 (0) 1.1 0.4–2.6 1.4 0.5–3.7
Buhimba 14 (4) 7 (50) 2.3 0.8–6.8 2.4 0.7–7.7
Kiziranfumbi 149 (42) 51 (34) 1.2 0.7–1.9 1.0 0.6–1.8
1The reference category consists of all other observations, which do not belong to the category (i.e. farming yes/no)
2 Slaughtering, skinning or butchering cattle
3 Slaughtering, skinning, butchering, milking or birthing cattle
4 these sub-counties were summarized in one category, bold = statistically signiﬁcant (p0.05)
doi:10.1371/journal.pntd.0004858.t001
Table 2. Serovar panel, seroprevalence of Leptospira serovars and serogroups by Microscopic Agglutination Test (titer1:100) among 359
humans sampled in Hoima, Uganda.
Leptospira Serovar Serogroup N positive Prevalence* 95% CI
L. borgpetersenii sv Nigeria Pyrogenes 71 19.8% 15.9–24.4
L. borgpetersenii sv Hardjobovis** Sejroe 20 5.6% 3.5–8.6
L. interrogans sv Wolfﬁ** Sejroe 19 5.3% 3.3–8.3
L. kirschneri sv Butembo Autumnalis 8 2.2% 1.0–4.5
L. interrogans sv Bratislava Australis 7 1.9% 0.9–4.2
L. kirschneri sv Grippotyphosa Grippotyphosa 1 0.3% 0.0–1.5
L. interrogans sv Icterohemorrhagiae Icterohemorrhagiae 0 0.0% 0.0–1.0
L. biﬂexa sv Patoc Semaranga 0 0.0% 0.0–1.0
L. kirschneri Sokoine*** Icterohemorrhagiae - - -
L. borgpetersenii Kenya*** Ballum - - -
L. borgpetersenii Nona*** Hebdomadis - - -
Any Leptospira serovar Any positivity 126 35.0% 30.2–40.3
* This prevalence is an apparent prevalence, as the Microscopic Agglutination Test is not 100% sensitive and speciﬁc.
** Cross-reactions likely between serovars. Seven persons (1.9%) had MAT titers1:800 consistent with probable recent leptospirosis.
*** Did not grow properly and were not tested.
doi:10.1371/journal.pntd.0004858.t002
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Data Analysis
A seropositive case was defined as a MAT titer of1:100 against any serovar. A probable
recent leptospirosis case was defined as a MAT titer of1:800 [13,18]. The outcomes of inter-
est were the prevalence of study participants who were seropositive against each specific sero-
var, seropositive against any serovar, or seropositive with probable recent leptospirosis.
Past medical history was based on self-reported survey information. No biometric or
serological data were available to confirm self-reported data. Questionnaire information
and serologic test results were entered into Microsoft Access and analyzed using Excel and
Stata 10 (StataCorp, College Station, TX, USA). Data deposited in the Dryad repository:
http://dx.doi.org/10.5061/dryad.6ns6p [19]. Exploratory data analysis was conducted to eval-
uate crude associations using 2x2 tables, histograms and summary measures. To improve
power in the risk factor analysis, two composite variables were created to identify groups
with persons with intensive contact with livestock and potential exposure to livestock associ-
ated Leptospira serovars. The first composite variable included persons involved in slaughter-
ing, skinning and butchering cattle, while the second also included exposure to cattle milking
and birthing.
A sample size of 278 enabled a 95% confidence interval (95% CI) within a precision of ±5%
under the assumption that the true prevalence was 20% [20]. To detect an odds ratio of 2.5
with 80% power, a type I error of 0.05, prevalence of 9% in the exposed group, and an exposed
to non-exposed ratio of one-third, the required sample size was 280 study participants.
The association between the outcomes and exposure variables listed in Table 1 was analyzed
in two steps. Initial analysis included bivariable comparison of individual exposure variables
with outcomes by chi-square tests or logistic regression, followed by a multivariable logistic
regression. A manual forward and backward selection method was used to evaluate the associa-
tion between exposure and confounding variables with the outcome. Exposure variables were
entered in the model if the bivariable p-value was0.2 or if they represented biologically plau-
sible risk or confounding factors for the outcome and were kept in the model if the Likelihood
Ratio Test was statistically significant (p0.05).
Ethics Statement
All procedures involving human subjects were approved by the institutional review boards of
the University of Minnesota, USA and Joint Clinical Research Centre, Uganda and the Uganda
National Council of Science and Technology (UNCST). Potential participants were informed
of the study during their healthcare encounter. After their routine healthcare visit, each person
was given the opportunity to provide written informed consent.
Results
Study Population
A total of 359 participants provided informed consent, were interviewed, and had serum col-
lected. Of those approached for participation, approximately 50% consented to participate.
Participants originated from eight of 13 sub-counties in Hoima District of western Uganda,
although 89% (320/359) came from the subcounties immediately surrounding each Health
Centre. 71% of participants were women, and 69% (246/259) were<40 years of age. 81% par-
ticipated in farming as either a primary or secondary occupation, with a minority involved
with livestock on a daily basis, such as milking (7%), birthing (2.5%), slaughtering (1.7%), skin-
ning (1.7%) and in butchering (1%) (Table 1).
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Past Medical History and Disease
Over their lifetime, 87% (n = 312) of 359 study participants had self-reported diagnoses of
malaria, 16% (n = 56) typhoid, 4% (n = 16), brucellosis, and 1% (n = 4) reported a diagnosis of
tuberculosis. No participants reported a diagnosis of leptospirosis. For illnesses within the past
one year, 49% of participants reported a malaria diagnosis over the past year. Of participants
with malaria diagnoses, 49 participants (20%) noted having had a relapse of fever after initial
malaria treatment. Overall, 69% (n = 249) reported a history of fever within the past year, and
of those who reported a fever, 70% (175/249) received a clinical diagnosis of malaria. For other
illnesses, 8% (n = 20) self-reported typhoid enteric fever, and 5% (n = 12) self-reported a bru-
cellosis diagnosis in the past year.
Regarding other zoonotic infections within the communities, 16% (n = 58) of participants
reported to have known someone affected by brucellosis and 15% (n = 54) by rabies. No one
reported leptospirosis in the community.
Leptospira Seroprevalence and Antibody Titers
126 study participants (35.0%, 95%CI, 30.2–40.3%) were seropositive against any of the eight
serovars. The diversity of responses against the different serovars, representing different ser-
ogroups is listed in Table 2. The most frequent reactivity to a serovar was to sv. Nigeria sg Pyro-
genes at 19.8% (95% CI 15.9–24.4%, n = 71) which was statistically significantly higher than
the prevalence of other serovars (p<0.0001) (Table 2). The second highest prevalence was
caused by the sg Sejroe represented by sv Hardjobovis and sv Wolffii with 5.6% (95%CI 3.5–
8.6) and 5.3% (95%CI 3.3–8.3), respectively. A very low or nonexistent prevalence was found
against sv Bratislava sg Australis with 1.9% (95%CI 0.9–4.2), against sv & sg Grippotyphosa
with 0.1% (95%CI 0.0–0.1), and sv & sg Icterohemorrhagiae and sv Patoc sg Semaranga with
both 0.0% (95%CI 0.0–1.0).
The seroprevalence did not differ between the sub-counties, but the individual sub-county
samples sizes were very small (S1 Fig). Furthermore, the seroprevalence did not differ by age
group with 35% (54/155) of those aged 18–29 years, 29% (26/91) aged 30–39 years, 32% (19/
59) aged 40–49, and 34% (16/47) aged50 years being seropositive (P = 0.78) (Table 1).
Antibody titers against any serovar ranged from zero to 1:3200. The seven participants with
titers1:800 had solely antibodies against sv Nigeria (Fig 1). Therefore, the prevalence of prob-
able recent leptospirosis was 1.9% (95% CI 0.9–4.2%) and was uniquely related to sv Nigeria.
Eight (6.4%) of 125 seropositive participants had either been exposed to multiple serovars and/
or their sera cross-reacted in the MAT. There were double exposures (or cross-reactions)
between Nigeria andWolffi (n = 1), Nigeria and Butembo (n = 1), Nigeria and Bratislava
(n = 2), Nigeria and Hardjobovis (n = 2). Further, between Wolffi and Hardjo (n = 1) and Bra-
tislava and Butembo (n = 1).
Risk Factors for Probable Recent Leptospirosis and Seropositivity
All exposure variables (“risk factors”) listed in Table 1, including demographic, past medical
history, and occupational/behavioral exposures were tested for a statistically significant associ-
ation (p0.05) with the outcome “probable recent leptospirosis” by bivariable and multivari-
able analysis. Having been diagnosed with malaria in the past year was statistically significantly
associated with being a case of probable recent leptospirosis (P = 0.048) in the chi-square test.
However, in multivariable analysis, the association lost its statistical significance (OR 6.5, 95%
CI 0.8–5, P = 0.085). All other health history risk factors, including having had fever, a fever
that recurred after treatment, brucellosis, or typhoid in the past year, were not associated with
probable recent leptospirosis in either analysis.
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We further assessed risk factors listed in Table 1 for seropositivity against sv Nigeria, sv
Hardjobovis, sv Wolffi, sv Butembo and sv Bratislava and for seropositivity against any of the
eight serovars, by bivariable (Table 1) and multivariable analysis (Table 3). In the bivariable
analysis, six participants who reported having skinned cattle in the two weeks prior to their
blood sample had an odds ratio (OR) of 10.6 (95% CI 1.2–91.9, P = 0.032) for being seroposi-
tive against any serovar compared to participants who had not skinned cattle. People who
reported monkeys living near their home had 2.1 (95% CI 1.2–3.7 P = 0.018) and 1.8 (95% CI
1.1–3.0 P = 0.013) times the odds of seropositivity against sv Nigeria and any serovar, respec-
tively, compared to persons without monkeys nearby.
The statistically significant risk factors in the multivariable analysis are listed in Table 3.
Persons involved in skinning cattle had 9.8 (95% CI 1.0–96.0 P = 0.048) times the odds of sero-
positivity against sv Bratislava and 12.28 (95% CI 1.39–108.58 P = 0.024) times the odds of
seropositivity against any serovar, once adjusted for the effect of having monkeys near the
home. Individuals with monkeys near their home had 2.05 (95% CI 1.1–3.7 P = 0.018) and 1.92
(95% CI 1.2–3.1 P = 0.009) times the odds of seropositivity against sv Nigeria and any serovar
Fig 1. Frequency histogram showing the number of seropositive sera of patients (n = 359) at each MAT titer to different serovars.
doi:10.1371/journal.pntd.0004858.g001
Table 3. Multivariable logistic regression: significant effects on seroprevalence of Leptospira interrogans Bratislava, L. borgpetersenii Nigeria
and of any serovar listed in Table 2 among 359 humans sampled in Hoima, Uganda.
Outcome/Model Risk Factor Odds Ratio 95% CI P-Value
Positivity against sv Bratislava Skinning 9.88 1.01–96.04 0.048
Positivity against sv Nigeria Contact with monkeys 2.05 1.13–3.71 0.018
Positivity against any Leptospira sv Contact with monkeys 1.92 1.18–3.13 0.009
Positivity against any Leptospira sv Skinning 12.3 1.4–108.6 0.024
doi:10.1371/journal.pntd.0004858.t003
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respectively, once adjusted for the effect of skinning. Other variables tested, including the “live-
stock-contact” composite variables, ownership of livestock, consumption of animal products,
wildlife exposures other than monkeys around the home, and frequency of forest visits were
not significantly associated with seropositivity at the individual serovar or all serovar levels in
the bivariable and multivariable analysis. Similarly, no association was found between housing
materials or drinking water origin and Leptospira seropositivity.
Discussion
We found 35% prevalence of serum antibodies against eight Leptospira serovars in humans in
rural western Uganda. We further detected a seroprevalence of 20% against sv Nigeria sg Pyro-
genes, which was the most frequent serovar or serogroup for exposure. Historically, sv Nigeria
was isolated from bovine kidneys in Nigeria [21]. The high prevalence of antibodies against sv
Nigeria raises concern for a bovine-human transmission pathway in western rural Uganda that
deserves further examination. Despite their lower seroprevalence, the presence of antibodies
against cattle-associated serovars Wolffi (5%) and Hardjobovis (6%) of the sg Sejroe also
strengthen the cattle transmission hypothesis. [22–24].
In addition to the high overall seroprevalence, the prevalence of probable recent leptospiro-
sis was 1.9%. The 1.9% of individuals with titers reflective of probable recent leptospirosis fur-
ther emphasizes the potential public health relevance of serogroup Pyrogenes in Uganda. If the
MAT cut-off for probable leptospirosis was lowered to a titer of1:400 [25], which has been
used in other studies, 5.6% (95% CI, 3.5–8.6%) of participants would fit the case definition of
probable recent leptospirosis. In the bivariable analysis, probable recent leptospirosis was sta-
tistically significantly associated with the person having had malaria in the past year. One pos-
sible explanation for this association is the oft-lamented concern that leptospirosis may
frequently be misdiagnosed as malaria. However this association should be considered cau-
tiously, as fever and past medical history were purely self-reported variables, and may have sig-
nificant inherent error and recall bias.
Had all participants specifically come to the health centers due to acute febrile illness, the
prevalence of probable recent leptospirosis might have been higher, given that Biggs et al. [13]
found that 9% of patients had confirmed leptospirosis who were admitted for acute febrile ill-
ness at two health centers in northern Tanzania. Although such clinical inclusion criteria were
not used in our study due to ethical concerns, our estimates were more representative of the
general population instead of a selected sub-sample of persons presenting only with febrile ill-
ness. However, some serovars of the species L. borgpetersenii have been shown to cause primar-
ily asymptomatic infection in humans, making further characterization of sv Nigeria essential
to understanding its importance in this community.
Of similar importance is the 0% seroprevalence to L. interrogans sv. Icterohemorrhagiae,
traditionally associated with severe clinical infection. The ecology of different serovars has not
been described for the study region, but possible explanations include that this serovar may not
be present in this region, or that it is less likely to be found in relatively healthy, outpatient
clinic visitors. This emphasizes the importance of further study of leptospirosis in clinically ill
patients presenting with undifferentiated febrile disease.
Skinning of cattle was associated with seropositivity. Skinning is a biologically plausible risk
factor for Leptospira seropositivity, as contact with contaminated urine is possible during the
slaughter process. Why skinning and not the actual slaughter of cattle was associated is unclear,
but may be due to a higher duration of exposure during the more intricate skinning process as
opposed to the relatively brief exposure when cattle are killed. Similarly, skinning has been
found to be the strongest risk factor for seroconversion in sheep slaughtering abattoirs in New
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Zealand [26]. The low sample size (n = 6) led to limited power to analyze risk factors and may
be responsible for either artificially exaggerating the association with skinning or minimizing
the association with other high risk behaviors. Given the consistency of these results with other
studies, overall the risk factor analysis supports the bovine-human transmission hypothesis.
The association between having monkeys living near the home and seropositivity for lepto-
spirosis is more ambiguous. These individuals may live in more remote areas with greater wild-
life contact in general, thus giving them more exposure to wildlife classically associated with
leptospirosis. The possibility of a more direct role for monkeys in the transmission of lepto-
spires to humans in Uganda is not established here but could also be further explored. Lepto-
spirosis is commonly associated with contact to rodents, however the ubiquitous exposure to
rats limited the ability of the study to assess the role of rodent exposures.
The study design and the sampling approach have limitations which may affect generaliz-
ability. First, the participants of this cross-sectional study were a convenience sample of those
who attended two health clinics for a variety of health problems. Although each Health Centre
IV has a theoretical catchment area that covers half of Hoima District, in practice the large
majority of patients came from the subcounties immediately surrounding each Health Centre.
As a result, the more rural parts of Hoima, including the Kyangwali refugee camp, were highly
underrepresented. Furthermore, the study population included only those18 years old and
women were overrepresented (71%), whereas in general the population of Hoima is 50%
female. In rural areas, women were expected to have a lower Leptospira seroprevalence than
men, due to differences in occupational exposures (i.e. high-risk livestock activities), but the
overall seroprevalences in women (32%) and men (34%) were similar. Persons working in live-
stock were also under-represented, and more systematic population sampling may have
revealed an even higher seroprevalence.
Alternatively, the seroprevalence may have been overestimated, as this was a predominantly
outpatient clinic population and patients were more likely to be ill compared to the population
at large. Since many of the participants had fever symptoms in the past year (70%), it is possible
Leptospira seroprevalence was higher in the study population than in the general population.
However, fever is a very common symptom, especially in rural Africa; hence it is plausible that
70% of the general population will have experienced a fever episode within one year.
The limited sampling period may also have affected the seroprevalence. March-May is tradi-
tionally a rainy season within Hoima, which could potentially increase the rates of acute lepto-
spirosis. However, the season was drier than usual, and there were no episodes of flooding in
the town center or health centers. Furthermore, while such immediate weather conditions
might be reasonably blamed for acute, high titer cases; overall seropositivity for exposure
should be less affected. Hence, there were many potential reasons for the study to have under-
estimated or overestimated community-level seroprevalence.
The definition of the variables involving contact with cattle (including skinning) were not
ideal, as the exposure time was set for the last two weeks prior to the interview. The time span
may have been too short for some participants to seroconvert in cases of exposure to Leptospira
through animal contact. However, most people who endorsed having had contact with cattle
within the two weeks prior to the interview will most likely also have had similar prior contact,
as skinning or butchering are usually regular activities and antibodies may persist between sev-
eral months and years [2,27]. Others may have had more remote exposures to these activities
that were not captured by the survey. Finally, some of the analyzed exposures occurred rarely,
leading to low power for the risk factor analysis (Table 1).
Since laboratory capacity for the MAT did not exist in Uganda, antigens and antisera were
imported from theWHO reference laboratory in Holland, and the size of the serovar panel was
limited. The chosen panel was not large enough to cover all the common serogroups, and may
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not encompass all local strains. Hence, the overall prevalence may have been underestimated in
this study. Since testing was targeted towards past exposure to leptospires and not acute disease,
a MAT sensitivity of 88% and specificity of 98% can be assumed [25]. Therefore, the tested
prevalence is an “apparent seroprevalence” and will most likely be slightly underestimated.
An undisputed limitation is the lack of clinical data during the sampling phase. It would
have been highly informative to analyze the association between febrile illness and high lepto-
spirosis titers. Due to ethical concerns with collecting clinical data without the ability to imme-
diately diagnose (diagnostic capacity for MAT or PCR was unavailable in Uganda during the
sampling period) or treat individual patients, data on clinical status such as the presence of
fever, subsequent symptoms or symptom duration was not collected. However, as a result of
the capacity building component of this study, laboratory diagnosis of leptospirosis will be
available to support future clinical studies.
This initial study on leptospirosis in Uganda raises several research questions of interest for
future studies. We recommend further exploration of the “bovine-human transmission path-
way” by testing sera (MAT) and urine/kidneys (PCR) of bovines and sera of humans working
in their proximity, either in farming/pastoral communities or in abattoirs. Additional testing of
rat kidneys for the presence of leptospires may help evaluate the significance of the bovine-
human transmission pathway relative to classically described murine-human transmission. In
order to estimate the burden of leptospirosis in Uganda and the clinical importance of preva-
lent serovars, a study in patients with acute febrile illness would also be useful. A case-control
study within this study population could assess risk factors in their community, such as loca-
tion, flooding, contact with different animal species and occupational activities. Yet, before
launching a large surveillance study of specific serovars for a new region/country, one consider-
ation might be first sampling abattoirs as likely hotspots of exposure. In testing abattoir work-
ers’ serum for an extensive range of serovars, one might determine which serovars are
circulating in a community and then perform targeted testing of acute febrile illness patients
using a less expansive, less costly panel. Working in such hotspots may also facilitate isolation
of actual pathogenic leptospires.
This is to our knowledge the first article reporting on the prevalence of antibodies against
Leptospira serovars in humans in Uganda. The 35% prevalence of antibodies to Leptospira sug-
gests frequent exposure to this pathogen, in particular the Nigeria serovar of the Pyrogenes ser-
ogroup. Given this exposure, leptospirosis may have a greater impact on the health of this
population than previously recognized. Further research is needed to understand the public
health impact of leptospirosis in Uganda.
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